# Loxapine

NDC: 0527-1396
Generic name: Loxapine
Labeler / Manufacturer: Lannett Company, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20110926

FDA application: ANDA090695

## Active ingredients

- LOXAPINE SUCCINATE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0527-1396"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0527-1396
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=509bad3c-b563-4042-b270-d28bde19f224